Science Release: Hubble solves merger mystery from Milky Way’s early years

Our home galaxy, the Milky Way, grew to its current size in part by consuming smaller galaxies. Now, new data from the NASA/ESA Hubble Space Telescope show definitive evidence of a dwarf galaxy merging with the young Milky Way galaxy in. The institutional report frames the development in practical terms and ties it to the broader mission or observing effort.

That matters because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. Now, new data from the NASA/ESA Hubble Space Telescope show definitive evidence of a dwarf galaxy merging with the young Milky Way galaxy in the earliest phases of its evolution. The results were published today in the journal Nature Astronomy.

It has grown by forming new stars from its gas clouds as well as collecting stars, gas, and dark matter from other galaxies through mergers. The most recent massive merger in our galaxy’s history took place with the Sagittarius dwarf galaxy, beginning over 6 billion years ago and still ongoing today.

Looking back into the even more distant past, researchers learned that the Milky Way galaxy consumed another dwarf galaxy called Gaia-Sausage-Enceladus 10 billion years ago. Now, Hubble has uncovered definitive evidence of an earlier merger that occurred about 11.8 billion years ago, or just 2 billion years after the Big Bang.

Our home is the Milky Way galaxy, but we do not know how our house was built,” said Davide Massari, lead author, Astrophysics and Space Science Observatory of Bologna in Italy. In this paper we discover where the first significant batch of bricks came from: a dwarf galaxy that we call LKH.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

Researchers used Hubble to study some of the Milky Way galaxy’s globular clusters: immense, roughly spherical collections of tens of thousands to a few million stars. Thanks to the high resolution and depth of Hubble imaging, we could measure the age and the metal content of these clusters with unprecedented precision,” said Chiara Zerbinati.

Because the account originates with ESA Hubble News, it functions best as a primary institutional report that is close to the data and operations, not as independent scientific validation. Institutional communications are produced by organizations with legitimate interests in presenting their work in a favorable light, which does not make them unreliable but does make them partial. Details that complicate the narrative, including instrument limitations, unexpected failures and results below projections, tend to be minimized relative to progress messages. Technical documentation and peer-reviewed publications, where they exist, provide the complementary layer that institutional releases cannot substitute.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source